Although HIF1α and HIF2α share many of the same target genes, HIF1α is postulated to act as a tumor suppressor while HIF2α has a pro-oncogenic function in ccRCC [26, 27]. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.